Fighting Addictions, Improving Lives: COmprehensive Drug Rehabilitation With Music

FALCO is a parallel pragmatic randomized control trial addressing long-term effects of music therapy (MT) on substance use disorder (SUD). 600 participants will be recruited from multiple European countries (see Locations). They will be randomized into one of the following intervention arms: Active Music Group (AMG), Music Listening Group (MLG) or Treatment as Usual (TAU) as offered locally.

NCT Number	NCT07028983
Lead Sponsor	NORCE Norwegian Research Centre AS Collaborators: University of Bergen, Helse Stavanger HF, Sykehuset Innlandet HF, University of Vienna, Anton Proksch Institut, University of Music and Performing Arts, Vienna, Austrian Institute for Health Technology Assessment GmbH, Herzog College, Bar-Ilan University, Israel, University of Pavia, University of Gdańsk, Wojewódzki Ośrodek Terapii Uzależnień w Gdańsku, Institut d'Investigació Biomèdica de Bellvitge, Institució Catalana de Recerca i Estudis Avançats, Universitat de Girona, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta, Fundació Sanitària d'Igualada, University of Zurich
Conditions	Substance Use Disorder (SUD)
Enrollment	600 participants
Start Date	2025-07-01
Primary Completion	2028-06-30 (estimated)
Study Completion	2037-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-01